Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...

Podrobná bibliografie
Hlavní autoři:	Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S
Médium:	Journal article
Vydáno:	Frontiers Media 2018

Podobné jednotky

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Autor: Sarah Westwood, a další
Vydáno: (2018-12-01)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
Autor: Westwood, S, a další
Vydáno: (2017)

New CSF biomarkers on the block
Autor: Charlotte E Teunissen, a další
Vydáno: (2016-09-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
Autor: Rosha Babapour Mofrad, a další
Vydáno: (2019-12-01)

Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
Autor: Nevado-Holgado, A, a další
Vydáno: (2016)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
Autor: Eleonora M. Vromen, a další
Vydáno: (2022-01-01)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
Autor: Baird, A, a další
Vydáno: (2015)

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
Autor: Alejo J Nevado-Holgado, a další
Vydáno: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Autor: Betty Marije Tijms, a další
Vydáno: (2021-08-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
Autor: Yong-Jin Park, a další
Vydáno: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
Autor: Sanna Hellberg, a další
Vydáno: (2019-03-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Autor: Teunissen, C, a další
Vydáno: (2018)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
Autor: Lyduine E. Collij, a další
Vydáno: (2023-11-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
Autor: Si Eun Kim, a další
Vydáno: (2020-01-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
Autor: Eline A. J. Willemse, a další
Vydáno: (2021-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
Autor: Stephanie J B Vos, a další
Vydáno: (2014-01-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
Autor: Yanaika S. Hok‐A‐Hin, a další
Vydáno: (2023-07-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
Autor: Winchester, L, a další
Vydáno: (2018)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
Autor: Mark R. Battle, a další
Vydáno: (2018-12-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Autor: Charlotte E. Teunissen, a další
Vydáno: (2018-03-01)

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
Autor: Vandenberghe, R, a další
Vydáno: (2013)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
Autor: Young-Sil An, a další
Vydáno: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
Autor: Taesik Yun, a další
Vydáno: (2020-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
Autor: Juhan Reimand, a další
Vydáno: (2019-12-01)

Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
Autor: Westwood, S, a další
Vydáno: (2016)

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Autor: Vandenberghe, R, a další
Vydáno: (2010)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
Autor: Hugh G. Pemberton, a další
Vydáno: (2023-05-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
Autor: Chan Ju Ryu
Vydáno: (2022-12-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
Autor: Fiona Heeman, a další
Vydáno: (2019-03-01)

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank
Autor: Cullen, B, a další
Vydáno: (2018)

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
Autor: Nevado-Holgado, A, a další
Vydáno: (2016)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
Autor: Winchester, L, a další
Vydáno: (2022)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
Autor: LEI Zhe, a další
Vydáno: (2022-07-01)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
Autor: Milos D. Ikonomovic, a další
Vydáno: (2018-06-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
Autor: Hiroshi Matsuda, a další
Vydáno: (2021-01-01)

Blood based proteomic biomarkers of Alzheimer’s disease pathology
Autor: Alison Louise Baird, a další
Vydáno: (2015-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
Autor: Carla M. Startin, a další
Vydáno: (2019-03-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
Autor: Laura M. Winchester, a další
Vydáno: (2018-06-01)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
Autor: Wesenhagen, KEJ, a další
Vydáno: (2025)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
Autor: Kirsten E. J. Wesenhagen, a další
Vydáno: (2025-03-01)